
Dr Martens PLC
LSE:DOCS

Intrinsic Value
The intrinsic value of one
DOCS
stock under the Base Case scenario is
120.92
GBX.
Compared to the current market price of 61.05 GBX,
Dr Martens PLC
is
Undervalued by 50%.
The Intrinsic Value is calculated as the average of DCF and Relative values:

Valuation History
Dr Martens PLC
Fundamental Analysis


Revenue & Expenses Breakdown
Dr Martens PLC
Balance Sheet Decomposition
Dr Martens PLC
Current Assets | 436m |
Cash & Short-Term Investments | 94.9m |
Receivables | 93.2m |
Other Current Assets | 247.9m |
Non-Current Assets | 496.4m |
Long-Term Investments | 1m |
PP&E | 206.3m |
Intangibles | 273.8m |
Other Non-Current Assets | 15.3m |
Free Cash Flow Analysis
Dr Martens PLC
GBP | |
Free Cash Flow | GBP |
Earnings Waterfall
Dr Martens PLC
Revenue
|
805.9m
GBP
|
Cost of Revenue
|
-277.9m
GBP
|
Gross Profit
|
528m
GBP
|
Operating Expenses
|
-447.5m
GBP
|
Operating Income
|
80.5m
GBP
|
Other Expenses
|
-51.1m
GBP
|
Net Income
|
29.4m
GBP
|
DOCS Profitability Score
Profitability Due Diligence
Dr Martens PLC's profitability score is 58/100. The higher the profitability score, the more profitable the company is.

Score
Dr Martens PLC's profitability score is 58/100. The higher the profitability score, the more profitable the company is.
DOCS Solvency Score
Solvency Due Diligence
Dr Martens PLC's solvency score is 40/100. The higher the solvency score, the more solvent the company is.

Score
Dr Martens PLC's solvency score is 40/100. The higher the solvency score, the more solvent the company is.
Wall St
Price Targets
DOCS Price Targets Summary
Dr Martens PLC
According to Wall Street analysts, the average 1-year price target for
DOCS
is 83.2 GBX
with a low forecast of 69.69 GBX and a high forecast of 107.1 GBX.
Dividends
Current shareholder yield for DOCS is
.
Shareholder yield represents the total return a company provides to its shareholders, calculated as the sum of dividend yield, buyback yield, and debt paydown yield. What is shareholder yield?
The intrinsic value of one
DOCS
stock under the Base Case scenario is
120.92
GBX.
Compared to the current market price of 61.05 GBX,
Dr Martens PLC
is
Undervalued by 50%.